Clinical Trials Directory

Trials / Conditions / Lung Infection

Lung Infection

33 registered clinical trials studyying Lung Infection8 currently recruiting.

StatusTrialSponsorPhase
RecruitingFMT for Lung and Associated-organ Rescue Efficacy in ARDS Patients
NCT06970262
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/A
RecruitingRadiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
NCT06648317
Peking University Cancer Hospital & Institute
Enrolling By InvitationNext-generation Sequencing Technology in the Clinical Application of Respiratory Specimens
NCT07191080
Bin Zhang
RecruitingIdentification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Bre
NCT06528418
ChromX Health
RecruitingEvaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscop
NCT05973201
Assistance Publique - Hôpitaux de ParisN/A
Active Not RecruitingA Study of the Clinical Benefit of Tobramycin Inhalation Solution
NCT06106789
Qianfoshan Hospital
CompletedStudy to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibr
NCT05616221
Armata Pharmaceuticals, Inc.Phase 2
RecruitingEffects of Prone Position After Major Abdominal Surgery
NCT05630443
Vastra Gotaland RegionN/A
UnknownPopulation Pharmacokinetics of Lassila Tazobactam in Patients After Aortic Dissection
NCT05349305
The Second Hospital of Shandong University
CompletedTAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
NCT05752019
Erasmus Medical Center
UnknownAerosolisation During Respiratory Procedures
NCT04741217
Guy's and St Thomas' NHS Foundation Trust
CompletedPh 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aerugi
NCT04596319
Armata Pharmaceuticals, Inc.Phase 1 / Phase 2
TerminatedDeveloping Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
NCT02748798
Thunder Bay Regional Health Research InstituteEARLY_Phase 1
CompletedCOVID-19 and Lung Ultrasound Utility
NCT04591158
Bridge to Health Medical and Dental USAN/A
CompletedOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
NCT04467840
RedHill Biopharma LimitedPhase 2 / Phase 3
WithdrawnTreatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
NCT04502069
RedHill Biopharma LimitedPhase 1 / Phase 2
UnknownEffects of Immunonutrition in Patients With Pneumonia
NCT04249050
University of CopenhagenN/A
UnknownThe Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchie
NCT04142827
Dr. Giuseppe FiorentinoN/A
UnknownDiagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL
NCT04051372
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CompletedAdjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
NCT03816956
Aridis Pharmaceuticals, Inc.Phase 3
TerminatedBiomarker for Cystic Fibrosis
NCT02710383
CENTOGENE GmbH Rostock
CompletedBreath and Air Stacking on Respiratory Mechanics in Tracheostomized Patients
NCT04012489
Brazilian Institute of Higher Education of CensaN/A
RecruitingCLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
NCT03236987
Centre Hospitalier Universitaire, AmiensPhase 3
RecruitingUNC Pleural Fluid Registry
NCT05620329
UNC Lineberger Comprehensive Cancer Center
TerminatedA Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic
NCT03309358
Synspira, Inc.Phase 1
CompletedVentilator Hyperinflation With Increase of Inspiratory Time
NCT03630510
Brazilian Institute of Higher Education of CensaN/A
CompletedDetecting Lung Infections Through Vibration
NCT02056860
University of Florida
CompletedPilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patien
NCT02109822
University of Washington
TerminatedReduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)
NCT02173613
University Hospital, GrenobleN/A
UnknownEffectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage
NCT00815737
Fudan UniversityPhase 2 / Phase 3
CompletedSafety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild L
NCT00712166
Gilead SciencesPhase 3
CompletedAztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
NCT01055847
Gilead SciencesPhase 2
TerminatedSafety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
NCT00043355
InterMunePhase 2